These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 34799250)

  • 1. Validating the UK prospective diabetes study outcome model 2 using data of 94,946 Israeli patients with type 2 diabetes.
    Zhuo X; Melzer Cohen C; Chen J; Chodick G; Alsumali A; Cook J
    J Diabetes Complications; 2022 Jan; 36(1):108086. PubMed ID: 34799250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the UK Prospective Diabetes Study Outcomes Model 2 in a Contemporary UK Type 2 Diabetes Trial Cohort.
    Keng MJ; Leal J; Mafham M; Bowman L; Armitage J; Mihaylova B
    Value Health; 2022 Mar; 25(3):435-442. PubMed ID: 35227456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of mortality and major cardiovascular complications in type 2 diabetes: External validation of UK Prospective Diabetes Study outcomes model version 2 in two European observational cohorts.
    Pagano E; Konings SRA; Di Cuonzo D; Rosato R; Bruno G; van der Heijden AA; Beulens J; Slieker R; Leal J; Feenstra TL
    Diabetes Obes Metab; 2021 May; 23(5):1084-1091. PubMed ID: 33377255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of the UKPDS Outcomes Model 2 for Predicting Death and Cardiovascular Events in Patients with Type 2 Diabetes Mellitus from a German Population-Based Cohort.
    Laxy M; Schöning VM; Kurz C; Holle R; Peters A; Meisinger C; Rathmann W; Mühlenbruch K; Kähm K
    Pharmacoeconomics; 2019 Dec; 37(12):1485-1494. PubMed ID: 31350720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of the CHIME simulation model to assess lifetime health outcomes of prediabetes and type 2 diabetes in Chinese populations: A modeling study.
    Quan J; Ng CS; Kwok HHY; Zhang A; Yuen YH; Choi CH; Siu SC; Tang SY; Wat NM; Woo J; Eggleston K; Leung GM
    PLoS Med; 2021 Jun; 18(6):e1003692. PubMed ID: 34166382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of prediction models for cardiovascular and mortality risk in people with type 2 diabetes: An external validation in 23 685 adults included in the UK Biobank.
    Zhang Y; Jiong OX; Tang S; Tang YC; Wong CT; Ng CS; Quan J
    Diabetes Obes Metab; 2024 May; 26(5):1697-1705. PubMed ID: 38297974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82.
    Hayes AJ; Leal J; Gray AM; Holman RR; Clarke PM
    Diabetologia; 2013 Sep; 56(9):1925-33. PubMed ID: 23793713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refitting of the UKPDS 68 risk equations to contemporary routine clinical practice data in the UK.
    McEwan P; Bennett H; Ward T; Bergenheim K
    Pharmacoeconomics; 2015 Feb; 33(2):149-61. PubMed ID: 25344660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the UKPDS outcomes model for prediction of myocardial infarction and stroke in the ADDITION-Europe trial cohort.
    Tao L; Wilson EC; Griffin SJ; Simmons RK;
    Value Health; 2013; 16(6):1074-80. PubMed ID: 24041358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating risk factor progression equations for the UKPDS Outcomes Model 2 (UKPDS 90).
    Leal J; Alva M; Gregory V; Hayes A; Mihaylova B; Gray AM; Holman RR; Clarke P
    Diabet Med; 2021 Oct; 38(10):e14656. PubMed ID: 34297424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrovascular Risk Equations Based on the CANVAS Program.
    Willis M; Asseburg C; Slee A; Nilsson A; Neslusan C
    Pharmacoeconomics; 2021 Apr; 39(4):447-461. PubMed ID: 33580867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study.
    Davis WA; Colagiuri S; Davis TM
    Med J Aust; 2009 Feb; 190(4):180-4. PubMed ID: 19220181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of mortality and macrovascular complications in type 2 diabetes: validation of the UKPDS Outcomes Model in the Casale Monferrato Survey, Italy.
    Pagano E; Gray A; Rosato R; Gruden G; Perin PC; Merletti F; Bruno G
    Diabetologia; 2013 Aug; 56(8):1726-34. PubMed ID: 23680916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External validation of the UKPDS risk engine in incident type 2 diabetes: a need for new type 2 diabetes-specific risk equations.
    Bannister CA; Poole CD; Jenkins-Jones S; Morgan CL; Elwyn G; Spasic I; Currie CJ
    Diabetes Care; 2014 Feb; 37(2):537-45. PubMed ID: 24089541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study.
    Guzder RN; Gatling W; Mullee MA; Mehta RL; Byrne CD
    Diabet Med; 2005 May; 22(5):554-62. PubMed ID: 15842509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes.
    van Dieren S; Peelen LM; Nöthlings U; van der Schouw YT; Rutten GE; Spijkerman AM; van der A DL; Sluik D; Boeing H; Moons KG; Beulens JW
    Diabetologia; 2011 Feb; 54(2):264-70. PubMed ID: 21076956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing 10-Year Cardiovascular Disease Risk in Malaysians With Type 2 Diabetes Mellitus: Framingham Cardiovascular Versus United Kingdom Prospective Diabetes Study Equations.
    Yew SQ; Chia YC; Theodorakis M
    Asia Pac J Public Health; 2019 Oct; 31(7):622-632. PubMed ID: 31535566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: accuracy of the Framingham, SCORE, and UKPDS risk functions: The Hoorn Study.
    van der Heijden AA; Ortegon MM; Niessen LW; Nijpels G; Dekker JM
    Diabetes Care; 2009 Nov; 32(11):2094-8. PubMed ID: 19875606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are population-based diabetes models useful for individual risk estimation?
    Saver BG; Hargraves JL; Mazor KM
    J Am Board Fam Med; 2011; 24(4):399-406. PubMed ID: 21737764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79.
    Davis TM; Coleman RL; Holman RR;
    Circulation; 2013 Mar; 127(9):980-7. PubMed ID: 23362315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.